Innospec Cash Flow Statement
NASDAQ: IOSPIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Innospec free cash flow
In fiscal 2025, Innospec generated $138.3 million of operating cash flow and spent $50.3 million on capital expenditures. That left free cash flow of $88.0 million, a free-cash-flow margin of 4.9% of revenue. Free cash flow was down 38.5% from the prior year's $143.1 million.
Innospec returned $66.3 million to shareholders: $42.4 million in dividends and $23.9 million in share repurchases, equal to 75% of free cash flow. Free cash flow covered dividend payments 2.1 times.
Summary generated from market data by MetaCap's automated system. Methodology
Innospec cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 116.60M | 35.60M | 139.10M | 133.00M | 93.10M | 28.70M | 112.20M | 85.00M | 61.80M | 81.30M |
| Net Income growth (YoY) | +227.53% | -74.41% | +4.59% | +42.86% | +224.39% | -74.42% | +32.00% | +37.54% | -23.99% | -31.97% |
| Depreciation & Amortization | 43.60M | 43.50M | 39.30M | 40.10M | 42.70M | 46.00M | 47.60M | 49.60M | 50.40M | 38.10M |
| Stock-Based Compensation | 8.10M | 8.50M | 8.00M | 6.70M | 4.40M | 5.80M | 6.60M | 4.90M | 4.10M | 3.30M |
| Change in Working Capital | -17.80M | -12.00M | 43.50M | -99.80M | -42.10M | 54.00M | 7.40M | -43.90M | -65.40M | -1.70M |
| Operating Cash Flow | 138.30M | 184.50M | 207.30M | 81.70M | 93.20M | 145.90M | 161.60M | 104.90M | 82.70M | 105.50M |
| Capital Expenditures | -50.30M | -41.40M | -62.10M | -39.60M | -39.10M | -29.70M | -29.90M | -28.90M | -23.30M | -16.50M |
| Investing Cash Flow | -75.10M | -62.00M | -111.80M | -42.10M | -36.20M | -29.70M | -31.00M | -35.50M | -29.60M | -209.10M |
| Dividends Paid | -42.40M | -38.80M | -35.10M | -31.70M | -28.80M | -25.60M | -25.00M | -21.70M | -18.60M | -15.90M |
| Share Repurchases | -23.90M | -700.00K | -1.10M | -5.90M | -800.00K | -2.10M | -2.40M | -1.40M | -1.10M | -8.40M |
| Debt Issued | — | — | — | — | — | — | — | — | — | 110.00M |
| Financing Cash Flow | -63.90M | -35.30M | -39.00M | -33.70M | -20.00M | -86.80M | -177.90M | -36.20M | -66.40M | 69.50M |
| Net Change in Cash | 3.30M | 85.50M | 56.60M | 5.30M | 36.50M | 29.60M | -47.40M | 32.90M | -11.70M | -35.00M |
| Free Cash Flow | 88.00M | 143.10M | 145.20M | 42.10M | 54.10M | 116.20M | 131.70M | 76.00M | 59.40M | 89.00M |
This table shows 10 annual periods of Innospec's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IOSP's reporting calendar. What is a cash flow statement?